Novalis LifeSciences Launches its First Life Science Investment Fund with $85 Million
August 20th , 2019, Novalis LifeSciences, an investment and advisory firm for the Life Science industry, announced today that it has raised $85M in capital for its first fund - Novalis LifeSciences Investments I, L.P.
Novalis LifeSciences is focused on highly innovative Life Science companies. On the occasion of closing the first fund, Marijn E. Dekkers, founder and chairman, said: “This first fund is a growth-oriented fund that will invest in 8-12 companies that are commercializing breakthrough technologies in various segments of the Life Science industry. This includes drug discovery, life science tools, genomics, synthetic biology, diagnostics, and agricultural biotechnology – all areas with huge unmet needs and exciting opportunities for investors”.
About Novalis LifeSciences
Novalis Lifesciences LLC, is a globally acting venture capital firm focused on breakthrough technologies in Life Science. Founded and managed by Dr. Marijn E. Dekkers, current chairman of Unilever and former chief executive officer of Bayer AG and Thermo Fisher Scientific Inc., Novalis works with a diversified group of project-based specialists leading in their respective life science fields.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CO-OPTIV-SECURITY23.9.2019 10:07:05 CEST | Press release
Businesses are Prioritising Cybersecurity Above All Else, Optiv Security Report Finds
CO-CLOVIS-ONCOLOGY-INC23.9.2019 10:02:35 CEST | Press release
Clovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals
SMARTSTREAM23.9.2019 10:02:35 CEST | Press release
SmartStream’s New Artificial Intelligence Module Uses Machine Learning for Digital Payments Processing
OAG23.9.2019 10:02:05 CEST | Press release
London Heathrow Remains No. 1 in Airport Connectivity for Third Straight Year
MERCK23.9.2019 09:02:09 CEST | Press release
CHMP Positive Opinion for Rebif® Label Amendment During Pregnancy as Clinically Needed and While Breastfeeding
SHANDONG-TAIER23.9.2019 09:02:09 CEST | Press release
China's Taierzhuang Ancient City: Pearl of the Beijing-Hangzhou Grand Canal Battlefield in the Anti-Japanese War
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom